Unlock instant, AI-driven research and patent intelligence for your innovation.

Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them

a technology of immunologically important epitopes and peptides, which is applied in the direction of peptide sources, carrier-bound/immobilised peptides, fusion polypeptides, etc., can solve the problem that peptides may not possess the correct overall charge or amino acid composition, are not available for antibody binding, and are not recognizable to antibody molecules

Inactive Publication Date: 2006-12-07
DE LEYS ROBERT
View PDF27 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The use of biotinylated peptides increases antigenicity, allowing for better detection of antibodies and improved immunological evaluation by maintaining the peptides' essential amino acids free for antibody recognition, even when not biotinylated, and enhances the sensitivity of assays.

Problems solved by technology

Despite the many advantages synthetic peptides offer, there are a number of disadvantages associated with their use.
Because of their small size, direct adsorption of peptides to the solid phase frequently gives rise to unsatisfactory results for any of a number of reasons.
Firstly, the peptide may not possess the correct overall charge or amino acid composition, which would enable the peptide to bind to the solid phase.
Secondly, the same amino acid residues, which are required for binding to the solid phase, may also be required for antibody recognition and therefore not available for antibody binding.
Thirdly, the peptide may become fixed in an unfavourable conformation upon binding to the solid phase, which renders it unrecognizable to antibody molecules.
While the amount of peptide bound to the solid phase, albeit indirectly, can in some cases be increased by this method, this approach suffers from the fact that the linkage between the peptide and the carrier protein frequently involves the side chains of internal trifunctional amino acids whose integrity may be indispensable for recognition by antibodies.
This approach will only be successful, however, as long as this amino acid is not a critical residue in the immunogenic sequence of interest and as long as the coupling agent chosen is sufficiently selective.
No single technique is applicable to all unprotected peptides regardless of their amino acid composition.
Unfortunately only 70% of HCV-infected individuals produce antibodies to NS4, neither the synthetic nor recombinant proteins containing sequences from this region are adequate for identifying all infected serum samples.
Deciding whether or not an epitope is diagnostically useful is not always straightforward and depends to an extent on the specific configuration of the test into which it is incorporated.
Epitopes which are not frequently recognized may or may not be diagnostically useful depending on the contribution they make towards increasing the detection rate of antibodies in true positive sera and the extent to which incorporation of these epitopes has an adverse effect on the sensitivity of the test due to dilution of other stronger epitopes.
While this method allows for very accurate mapping of linear epitopes, the length of the peptides, which can be reliably synthesized on the rods, is limited.
This may sometimes present problems if the length of the epitope exceeds the length of the peptides synthesized.
The disadvantage of this approach is that each peptide is chemically unique and that the conditions under which each peptide can be optimally coated onto a solid phase for immunological evaluation may vary widely in terms of such factors as pH, ionic strength, and buffer composition.
The determination of immunologically important epitopes using non-biotinylated peptides, which are covalently coupled to the solid phase, often fails to localize these epitopes.
Attachment of a biotin to the amino-terminus of such a peptide results in a structure which is significantly different from that found in the native protein and may, as a consequence, adversely affect the binding properties of biochemical properties of the peptide.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
  • Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
  • Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them

Examples

Experimental program
Comparison scheme
Effect test

example 2

Synthesis of N-α-Fmoc-Lys (N-ε-biotin)

A. Method A

[0282] Commercially available N-α-Fmoc-L-lysine (N-ε-tBoc) (1.5 grams) was treated with 20 milliliters of 95% trifluoroacetic acid, 5% H2O for 2 hours at room temperature. Most of the acid was then evaporated under a stream of nitrogen. Ten milliliters of water was added and the solution was extracted 3 times with diethylether. The aqueous phase was then evaporated to dryness in vacuo over phosphorus pentoxide. The resulting powder (N-α-Fmoc-L-lysine) was analyzed by reverse phase chromatography and revealed a homogeneous product which was, as expected, more hydrophilic than the starting material.

[0283] N-α-Fmoc-lysine (190 mg, 0.49 mmol) was dissolved in 8 milliliters of 0.1 M borate buffer, pH 8.7. N-hydroxysuccinimidobiotin (162 mg, 0.47 mmol) was dissolved in 4 milliliters of dimethylformamide and added to the solution of N-α-Fmoc-lysine. The pH was monitored and titrated as necessary, with NaOH. After 2 hours, the solution wa...

example 3

Methods for the Determination of Peptides Corresponding to Immunologically Important Epitopes in an Enzyme-Linked Immunosorbent Assay (ELISA) Using Specific Antibodies

[0286] Where peptides were to be coated directly, stock solutions of the peptides were diluted in sodium carbonate buffer, pH 9.6 and used to coat polystyrene microtiter plates at a peptide concentration of 2 to 5 micrograms per milliliter for 1 hour at 37° C.

[0287] In cases where biotinylated peptides were to be evaluated, plates were first coated with streptavidin in sodium carbonate buffer, pH 9.6 at a concentration of 3 micrograms per milliliter for 1 hour at 37° C. The plates were then washed to remove excess, unbound protein. A working solution of the biotinylated peptide at 1 microgram per milliliter in sodium carbonate buffer was then added to the wells of the microtiter plate and incubated for 1 hours at 37° C.

[0288] Once the plates had been coated with antigen, any remaining free binding sites on the plast...

example 4

Use of Biotinylated HIV Peptides for the Detection of HIV-Specific Antibodies

[0291] Experiments were performed to evaluate antibody recognition of short, 10 amino acid-long, N-acetylated peptides corresponding to other contained within the transmembrane proteins of HIV-1 and HIV-2. Direct coating of these peptides in the wells of microtiter plates gave very poor results when antibody binding was evaluated in an ELISA. Since it was suspected that the peptides did not bind well to the polystyrene solid phase, the peptides were resynthesized in the same way except that biotin was attached to the amino terminus of the peptides, separated from the decamer peptide sequence by three glycine residues whose function it was to serve as a linker arm. The peptides used for the comparison were as follows:

TM-HIV-1:Ac-Ile-Trp-Gly-Cys-Ser-Gly-Lys-Leu-(SEQ ID NO:110)Ile-Cys-NH2TM-HIV-1 BioBio-Gly-Gly-Gly-Ile-Trp-Gly-Cys-Ser-(SEQ ID NO:111)Gly-Lys-Leu-Ile-Cys-NH2TM-HIV-2Ac-Ser-Trp-Gly-Cys-Ala-Phe-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
concentrationaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The technical problem underlying the present invention is to provide peptides corresponding to immunologically important epitopes on bacterial and viral proteins, as well as the use of said peptides in diagnostic or immunogenic compositions. The invention relates to a process for the in vitro determination of antibodies, wherein the peptides used are biotinylated, particularly in the form of complexes of streptavidin-biotinylated peptides or of avidin-biotinylated peptides.

Description

[0001] This application is a divisional application of Ser. No. 10 / 621,675, filed Jul. 18, 2003 (pending), which is a divisional of application Ser. No. 09 / 576,824, filed May 23, 2000 (now U.S. Pat. No. 6,667,387), which is a divisional of application Ser. No. 08 / 723,425, filed Sep. 30, 1996, which is a divisional of application Ser. No. 08 / 146,028, filed Nov. 22, 1993, which is a 371 application of PCT / EP93 / 00517, which claims benefit of EP 92400598.6, filed Mar. 6, 1992, the entire content of each of which is hereby incorporated by reference in this application.DETAILS [0002] The technical problem underlying the present invention ell is to provide peptides corresponding to immunologically important epitopes on bacterial and viral proteins, as well as the use of said peptides in diagnostic or immunogenic compositions. [0003] Recent developments in genetic engineering as well as the chemistry of solid phase peptide synthesis have led to the increasingly wider use of synthetic peptid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/00C07K16/00C07K1/00A61K38/00C07K17/00C07K2/00C07K4/00C07K5/00C07K7/00C07K1/13C07K14/16C07K14/18G01N33/531G01N33/569G01N33/68
CPCC07K1/13C07K14/005C07K2319/00C12N2740/16022C12N2740/16122G01N2333/18C12N2770/24222G01N33/531G01N33/56983G01N33/56988G01N33/6878C12N2740/16222
Inventor DE LEYS, ROBERT
Owner DE LEYS ROBERT